Affordable Access

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer.

Authors
  • Kunitoh, H
  • Watanabe, K
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Jan 01, 1994
Volume
12
Issue
1
Pages
83–89
Identifiers
PMID: 8270989
Source
Medline
License
Unknown

Abstract

With long-term CI of etoposide, a Css greater than 1 or 1.2 micrograms/mL appeared necessary, but not sufficient, to achieve a major response against NSCLC.

Report this publication

Statistics

Seen <100 times